43 related articles for article (PubMed ID: 19105947)
1. [Expression of Pim-2 in normal liver and hepatocellular carcinoma tissues].
Li B; Ye T; Li DH
Zhonghua Gan Zang Bing Za Zhi; 2008 Dec; 16(12):950-1. PubMed ID: 19105947
[No Abstract] [Full Text] [Related]
2. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell.
Gong J; Wang J; Ren K; Liu C; Li B; Shi Y
J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992
[TBL] [Abstract][Full Text] [Related]
3. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver.
Wu Y; Wang YY; Nakamoto Y; Li YY; Baba T; Kaneko S; Fujii C; Mukaida N
Oncogene; 2010 Apr; 29(15):2228-37. PubMed ID: 20101231
[TBL] [Abstract][Full Text] [Related]
4. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors.
Zhang XK; Huang DP; Qiu DK; Chiu JF
Oncogene; 1990 Jun; 5(6):909-14. PubMed ID: 2163054
[TBL] [Abstract][Full Text] [Related]
5. ras oncogene p21 expression in hepatocellular carcinoma.
Jagirdar J; Nonomura A; Patil J; Thor A; Paronetto F
J Exp Pathol; 1989; 4(1):37-46. PubMed ID: 2550600
[TBL] [Abstract][Full Text] [Related]
6. Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.
Aho TL; Sandholm J; Peltola KJ; Mankonen HP; Lilly M; Koskinen PJ
FEBS Lett; 2004 Jul; 571(1-3):43-9. PubMed ID: 15280015
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of BUBR1 overexpression in hepatocellular carcinoma.
Liu AW; Cai J; Zhao XL; Xu AM; Fu HQ; Nian H; Zhang SH
J Clin Pathol; 2009 Nov; 62(11):1003-8. PubMed ID: 19861558
[TBL] [Abstract][Full Text] [Related]
8. Abnormal nucleotide repeat sequence in the TGF-betaRII gene in hepatocellular carcinoma and in uninvolved liver tissue.
Enomoto A; Esumi M; Yamashita K; Takagi K; Takano S; Iwai S
J Pathol; 2001 Oct; 195(3):349-54. PubMed ID: 11673833
[TBL] [Abstract][Full Text] [Related]
9. Expression of the c-met protooncogene in human hepatocellular carcinoma.
Suzuki K; Hayashi N; Yamada Y; Yoshihara H; Miyamoto Y; Ito Y; Ito T; Katayama K; Sasaki Y; Ito A
Hepatology; 1994 Nov; 20(5):1231-6. PubMed ID: 7927256
[TBL] [Abstract][Full Text] [Related]
10. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
Dai H; Li R; Wheeler T; Diaz de Vivar A; Frolov A; Tahir S; Agoulnik I; Thompson T; Rowley D; Ayala G
Prostate; 2005 Nov; 65(3):276-86. PubMed ID: 16015593
[TBL] [Abstract][Full Text] [Related]
11. Identification of immediate-early gene targets of the Raf-1 serine/threonine protein kinase using an estradiol-dependent fusion protein, delta Raf-1:ER.
McCarthy SA; Aziz N; McMahon M
Methods Mol Biol; 1997; 85():137-51. PubMed ID: 9276321
[No Abstract] [Full Text] [Related]
12. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
13. TORward AKTually useful mouse models.
Mellinghoff IK; Sawyers CL
Nat Med; 2004 Jun; 10(6):579-80. PubMed ID: 15170198
[No Abstract] [Full Text] [Related]
14. [The expression of bcl-xL mRNA in the tissues of normal liver and hepatocarcinoma].
Guo X; Shao X; Xu J; Zhao J; Wu C
Zhonghua Gan Zang Bing Za Zhi; 2002 Apr; 10(2):156. PubMed ID: 12108390
[No Abstract] [Full Text] [Related]
15. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
Price JA; Kovach SJ; Johnson T; Koniaris LG; Cahill PA; Sitzmann JV; McKillop IH
Hepatology; 2002 Nov; 36(5):1089-97. PubMed ID: 12395318
[TBL] [Abstract][Full Text] [Related]
16. c-fos and c-myc oncoprotein expression in human hepatocellular carcinomas.
Arbuthnot P; Kew M; Fitschen W
Anticancer Res; 1991; 11(2):921-4. PubMed ID: 1648336
[TBL] [Abstract][Full Text] [Related]
17. Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death.
Pircher TJ; Zhao S; Geiger JN; Joneja B; Wojchowski DM
Oncogene; 2000 Jul; 19(32):3684-92. PubMed ID: 10951575
[TBL] [Abstract][Full Text] [Related]
18. Expression and possible role of ets-1 in hepatocellular carcinoma.
Ito Y; Miyoshi E; Takeda T; Sakon M; Noda K; Tsujimoto M; Monden M; Taniguchi N; Matsuura N
Am J Clin Pathol; 2000 Nov; 114(5):719-25. PubMed ID: 11068545
[TBL] [Abstract][Full Text] [Related]
19. The human cervical cancer oncogene protein is a biomarker for human hepatocellular carcinoma.
Yoon SK; Lim NK; Ha SA; Park YG; Choi JY; Chung KW; Sun HS; Choi MJ; Chung J; Wands JR; Kim JW
Cancer Res; 2004 Aug; 64(15):5434-41. PubMed ID: 15289352
[TBL] [Abstract][Full Text] [Related]
20. [The research on the mechanism of Pim-2 suppressing the apoptosis of tumor cell].
Ren K; Shi YJ; Gong JP
Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):136-9. PubMed ID: 17633228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
